机构:[1]Department of Endocrinology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, People’s Republic of China昆明医科大学附属第一医院[2]Department of Clinical Laboratory, Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, People’s Republic of China[3]Department of Clinical Laboratory, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, People’s Republic of China昆明医科大学附属第一医院
National Natural Science Foundation of China (Grant No. 81660153, No.81660141) and Joint Research Found of Y unnan Provincial Science and T echnology Department-Kunming Medical University (Grant No. 2017FE468-197).
第一作者机构:[1]Department of Endocrinology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, People’s Republic of China
通讯作者:
通讯机构:[1]Department of Endocrinology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, People’s Republic of China[*1]Department of Endocrinology, First Affiliated Hospital of Kunming Medical University
推荐引用方式(GB/T 7714):
Zhang Xuxiang,Wang Yuming,Zuo Fan,et al.Effect of Insulin-Regulated FOXC2 Expression in Adipocyte Differentiation and Insulin Resistance.[J].DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY.2020,13:2801-2809.doi:10.2147/DMSO.S262950.
APA:
Zhang Xuxiang,Wang Yuming,Zuo Fan,Su Yandan,Liu Hua...&Nian Xin.(2020).Effect of Insulin-Regulated FOXC2 Expression in Adipocyte Differentiation and Insulin Resistance..DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY,13,
MLA:
Zhang Xuxiang,et al."Effect of Insulin-Regulated FOXC2 Expression in Adipocyte Differentiation and Insulin Resistance.".DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY 13.(2020):2801-2809